Monday , September 20 2021

Lung cancer is the deadliest in Latin America and the least medical aid



Photo: Bioguia.com

(Caracas, Nov. 9, News 24) –The Lung cancer is the deadliest neoplastic disease in Latin America and one of the most attention in the health care industry., launched a study by The Economist Intelligence Unit (EIU) on "Lung Cancer in Latin America: It's Time to Stop the Conversion".

The study, presented at the Mexican Cancer Society Congress (SMEO), analyzed data from 12 Latin American countries, suggesting that in Mexico, 99% of lung cancer cases are diagnosed in phases 3 or 4, while in the rest of the region, the rate is 85%.

Irene Mia, director of the EIU's global editorial board, said that there is not enough data or registration for this type of cancer in the Latin American region, therefore We worked to identify the three priority areas for health policy in the area of ​​cancer control: tobacco control, access and diagnostics premature

Health experts who have participated in research show that bias against this type of cancer is an obstacle that prevents more specific policies and resources related to other types of cancer.

"It's believed that patients who have smoked have got the disease," the doctor said Óscar Arrieta, Head of the Lung Unit at the National Cancer Institute (INCan) and noted that smoking is an addiction in which the Mexican state "has not done enough to prevent it."

Although smoking is still the main cause of lung cancer, 40% of the causes are due to unrelated causes, such as the presence of arsenic in water, air pollution and the use of firewood as fuel in kitchens.

In Mexico, this type of cancer is not covered by Seguro Popular, which covers more than 40% of the population who do not have private insurance or social security, which contributes to the situation in a country with a low level of tobacco control, access and early diagnostics.

In Latin America, 60 000 people die from lung cancer each year, while in 2010, 10 000 new cases of diseases were diagnosed in Mexico, and according to the Arrieta, by 2025 this figure will double to 20 000. That "mortality will be very similar".

Ricardo Pérez Cuevas, Director of Research at the National Public Health Institute, said that The study reflects the problems associated with prevention, diagnosis and treatment of lung cancer, and there is no consistent response to problems. associated with it in Latin America.

Pérez Cuevas said that Mexico, the INCan, the Mexican Health Foundation and the National Public Health Institute, are working on a proposal based on the cost of lung cancer and tobacco control that will be submitted to the Mexican authorities.

"Our hope is this policy Lung cancer care is sound, a fund is needed and we can improve access and the effectiveness of the treatment ", concluded a specialist.

With information from EFE


Post Review:
429


Source link